Panacea Life Sciences Holdings, Inc.

8-K Entered a material agreement; Other events May 16, 2024 8-K Changed accountants May 7, 2024 10-Q Quarter ended 2024-03-31 May 6, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Entered a material agreement; Took on a direct financial obligation Mar 7, 2024 8-K Entered a material agreement Feb 5, 2024 8-K/A Completed an acquisition or disposition Dec 8, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure Oct 5, 2023 8-K Entered a material agreement; Other events Oct 2, 2023 10-Q Quarter ended 2023-06-30 Aug 15, 2023 8-K Entered a material agreement; Regulation FD disclosure Jul 10, 2023 8-K Director or officer change Jun 2, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 10-K Fiscal year ended 2022-12-31 Mar 30, 2023 8-K Entered a material agreement; Took on a direct financial obligation Feb 14, 2023 8-K Other events Jan 23, 2023 8-K Entered a material agreement; Took on a direct financial obligation Dec 27, 2022 10-Q Quarter ended 2022-09-30 Nov 14, 2022 10-Q Quarter ended 2022-06-30 Aug 15, 2022 8-K Director or officer change Jul 22, 2022 10-K/A Fiscal year ended 2021-12-31 Jun 27, 2022 8-K Regulation FD disclosure Jun 10, 2022 10-K/A Fiscal year ended 2021-12-31 May 18, 2022 10-Q Quarter ended 2022-03-31 May 13, 2022 8-K Regulation FD disclosure May 3, 2022 10-K/A Fiscal year ended 2021-12-31 Apr 29, 2022 10-K Fiscal year ended 2021-12-31 Mar 31, 2022 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 4, 2022 8-K Changed accountants Dec 29, 2021 10-Q/A Quarter ended 2021-09-30 Dec 20, 2021 10-Q/A Quarter ended 2021-06-30 Dec 20, 2021 8-K Previously issued financials not reliable Dec 20, 2021 8-K/A Other events Dec 17, 2021 10-Q/A Quarter ended 2021-09-30 Dec 17, 2021 10-Q/A Quarter ended 2021-06-30 Dec 17, 2021 8-K Entered a material agreement Dec 1, 2021 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity Nov 24, 2021 10-Q Quarter ended 2021-09-30 Nov 22, 2021 8-K Director or officer change Oct 29, 2021